ADVANCED ACCELERATOR APPLICATIONS USA INC
Entity uei:JNM4NBNHFE66 · UEI JNM4NBNHFE66
Obligations by fiscal year
Awards (22)
| 36C26224F0015↗ PLUVICTO | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 15, 2023 – Oct 31, 2024 | $4.7M | — | 0 |
| 36C26125F0023↗ PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 1, 2024 – Sep 30, 2025 | $4.0M | — | 0 |
| 36C26225F0024↗ PLUVICTO AND LUTATHERA FY 25 | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Nov 1, 2024 – Oct 31, 2025 | $3.5M | — | 0 |
| 36C24926N0263↗ VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Dec 20, 2025 – Sep 30, 2026 | $2.9M | — | 0 |
| 36C25025N0272↗ LUTETIUM - PLUVICTO AND LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jan 1, 2025 – Dec 31, 2025 | $2.9M | — | 0 |
| 36C25724F0058↗ LUTETIUM (LU177) DOTATATE: QTY 20 LUTETIUM (LU177) PSMA: QTY 100 | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Feb 6, 2024 – Feb 5, 2025 | $2.4M | — | 0 |
| 36C25024F0286↗ PLUVICTO AND LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jan 1, 2024 – Dec 31, 2024 | $2.4M | — | 0 |
| 36C26124N0090↗ PLUVICTO PROSTATE CANCER TREATMENT | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 1, 2023 – Sep 30, 2024 | $1.8M | — | 0 |
| 36C26125F0002↗ PLUVICTO PROSTATE CANCER THERAPY VANCHCS | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 1, 2024 – Sep 30, 2025 | $1.7M | — | 0 |
| 36C25525N0176↗ PLUVICTO AND LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Feb 17, 2025 – Feb 15, 2026 | $1.4M | — | 0 |
| 36C25526N0132↗ PLUVICTO AND LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Feb 17, 2026 – Feb 16, 2027 | $1.2M | — | 0 |
| 36C25524N0136↗ PLUVICTO AND LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Feb 17, 2024 – Feb 16, 2025 | $1.1M | — | 0 |
| 36C25225F0020↗ PLUVICTO RADIOPHARM | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Nov 1, 2024 – Oct 31, 2025 | $1.1M | — | 0 |
| 36C26325N0290↗ PLUVICTO DO/TO | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 28, 2024 – Jan 30, 2025 | $299K | — | 0 |
| 36C26025N0127↗ RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jan 1, 2025 – Dec 31, 2025 | $233K | — | 0 |
| 36C24825N0073↗ NETSPOT | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 1, 2024 – Sep 30, 2025 | $225K | — | 0 |
| 36C25224F0122↗ LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Mar 5, 2024 – Sep 30, 2024 | $201K | — | 0 |
| 36C24224F0205↗ NUCLEAR MEDICINE | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Aug 19, 2024 – Dec 31, 2024 | $167K | — | 0 |
| 36C25525N0282↗ PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) EXTENSION | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Mar 28, 2025 – Jul 31, 2025 | $166K | — | 0 |
| 36C25224F0104↗ LUTATHERA | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Feb 9, 2024 – Aug 31, 2024 | $157K | — | 0 |
| 36C25224N0197↗ LUTATHERA FOR DIRECT PATIENT CARE | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Dec 7, 2023 – Aug 30, 2024 | $157K | — | 0 |
| 36C24225N0129↗ PLUVICTO | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 1, 2024 – Sep 30, 2025 | $133K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- ADVANCED ACCELERATOR APPLICATIONS USA INC
JNM4NBNHFE66· seen 113×